MarcMathiasMD

Ophthalmology • Aurora, CO

Retinal Disease

Physician

Join to view full profile

Dr. Mathias is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mathias' full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

University of ColoradoFellowship, Surgical Retina and Vitreous, 2012 - 2014
University of ColoradoResidency, Ophthalmology, 2009 - 2012
Ohio State University HospitalInternship, Internal Medicine, 2008 - 2009
Ohio State University College of MedicineClass of 2008

Certifications & Licensure

CO State Medical License 2012 - 2025
OH State Medical License 2008 - 2010
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) Start of enrollment: 2020 Jun 09
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

3 citations
Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate.
Talisa E de Carlo Forest, Zafar Gill, Andres Lisker-Cervantes, Ramya Gnanaraj, Nathan Grove
American Journal of Ophthalmology. 2024-08-01
Differences in imaging biomarkers between patients with intermediate and advanced non-neovascular age-related macular degeneration (AMD) in the University of Colorado ...
Andres Lisker-Cervantes, Zafar Gill, Ramya Gnanaraj, Vivian Rajeswaren, Nihaal Mehta
European Journal of Ophthalmology. 2024-05-09
Elevated tumor necrosis factor alpha and vascular endothelial growth factor in intermediate age-related macular degeneration and geographic atrophy.
Vivian Rajeswaren, Brandie D Wagner, Jennifer L Patnaik, Naresh Mandava, Marc T Mathias
Frontiers in Ophthalmology. 2024-01-01

Press Mentions

4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-125 by Intravitreal Injection for the Treatment of X-linked Retinitis PigmentosaAugust 19th, 2020
University of Colorado Ophthalmologists Administer Novel Treatment for Single Patient Facing Rare Genetic ConditionSeptember 7th, 2023
Mini-Retinas Model Human Disease in a DishJuly 18th, 2024